Neuroprotection in Synaptic Signalling During Neurological Disorders
- Autores
- Otero losada, Matilde Estela; Wandosell, Francisco G.; Capani, Francisco
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Some of the most devastating and costly conditions in the world arise from neurological andneurodegenerative disorders. About one-third of the world's population suffers from neurologicaldiseases, including Parkinson's (PD) and Alzheimer's (AD) diseases, multiple sclerosis, epilepsy, spinal cord injury, and others. Symptoms may show early in childhood or substantially delayedin adolescence or young adulthood. Animal models are powerful tools aiding in understandingneurological pathophysiology towards developing neuroprotective strategies.So far, there are no well-established treatments for brain repair. Hence, neuroprotectionbecomes imperative. Synapses pose major targets for finding new neuroprotective agents.The aimof this topic is to share research addressing neuroprotective strategies for the brain, theirpossible pathways, and the use of pharmacological analogues. Four reviews are about hypoxia. Twochapters address themolecular bases of cognitive impairment in AD. Biochemical and physiologicalaspects of neuroprotective agents focusing on synaptic modifications, neuroprotection followingperinatal asphyxia, and pharmacological- and genetic-targeting strategies for Alzheimer's and Parkinson's diseases are reviewed.
Fil: Otero losada, Matilde Estela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires; Argentina
Fil: Wandosell, Francisco G.. Universidad Autónoma de Madrid; España. Consejo Superior de Investigaciones Científicas; España
Fil: Capani, Francisco. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina - Materia
-
Neuroprotection
rats
hipocampo
cns - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/166054
Ver los metadatos del registro completo
id |
CONICETDig_dd449ff4c3217b572b548d86aced97d1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/166054 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Neuroprotection in Synaptic Signalling During Neurological DisordersOtero losada, Matilde EstelaWandosell, Francisco G.Capani, FranciscoNeuroprotectionratshipocampocnshttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Some of the most devastating and costly conditions in the world arise from neurological andneurodegenerative disorders. About one-third of the world's population suffers from neurologicaldiseases, including Parkinson's (PD) and Alzheimer's (AD) diseases, multiple sclerosis, epilepsy, spinal cord injury, and others. Symptoms may show early in childhood or substantially delayedin adolescence or young adulthood. Animal models are powerful tools aiding in understandingneurological pathophysiology towards developing neuroprotective strategies.So far, there are no well-established treatments for brain repair. Hence, neuroprotectionbecomes imperative. Synapses pose major targets for finding new neuroprotective agents.The aimof this topic is to share research addressing neuroprotective strategies for the brain, theirpossible pathways, and the use of pharmacological analogues. Four reviews are about hypoxia. Twochapters address themolecular bases of cognitive impairment in AD. Biochemical and physiologicalaspects of neuroprotective agents focusing on synaptic modifications, neuroprotection followingperinatal asphyxia, and pharmacological- and genetic-targeting strategies for Alzheimer's and Parkinson's diseases are reviewed.Fil: Otero losada, Matilde Estela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires; ArgentinaFil: Wandosell, Francisco G.. Universidad Autónoma de Madrid; España. Consejo Superior de Investigaciones Científicas; EspañaFil: Capani, Francisco. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; ArgentinaFrontiers Media2021-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/166054Otero losada, Matilde Estela; Wandosell, Francisco G.; Capani, Francisco; Neuroprotection in Synaptic Signalling During Neurological Disorders; Frontiers Media; Frontiers in synaptic neuroscience; 13; 746487; 6-2021; 1-31663-3563CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fnsyn.2021.746487/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fnsyn.2021.746487info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:07:23Zoai:ri.conicet.gov.ar:11336/166054instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:07:23.716CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Neuroprotection in Synaptic Signalling During Neurological Disorders |
title |
Neuroprotection in Synaptic Signalling During Neurological Disorders |
spellingShingle |
Neuroprotection in Synaptic Signalling During Neurological Disorders Otero losada, Matilde Estela Neuroprotection rats hipocampo cns |
title_short |
Neuroprotection in Synaptic Signalling During Neurological Disorders |
title_full |
Neuroprotection in Synaptic Signalling During Neurological Disorders |
title_fullStr |
Neuroprotection in Synaptic Signalling During Neurological Disorders |
title_full_unstemmed |
Neuroprotection in Synaptic Signalling During Neurological Disorders |
title_sort |
Neuroprotection in Synaptic Signalling During Neurological Disorders |
dc.creator.none.fl_str_mv |
Otero losada, Matilde Estela Wandosell, Francisco G. Capani, Francisco |
author |
Otero losada, Matilde Estela |
author_facet |
Otero losada, Matilde Estela Wandosell, Francisco G. Capani, Francisco |
author_role |
author |
author2 |
Wandosell, Francisco G. Capani, Francisco |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Neuroprotection rats hipocampo cns |
topic |
Neuroprotection rats hipocampo cns |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Some of the most devastating and costly conditions in the world arise from neurological andneurodegenerative disorders. About one-third of the world's population suffers from neurologicaldiseases, including Parkinson's (PD) and Alzheimer's (AD) diseases, multiple sclerosis, epilepsy, spinal cord injury, and others. Symptoms may show early in childhood or substantially delayedin adolescence or young adulthood. Animal models are powerful tools aiding in understandingneurological pathophysiology towards developing neuroprotective strategies.So far, there are no well-established treatments for brain repair. Hence, neuroprotectionbecomes imperative. Synapses pose major targets for finding new neuroprotective agents.The aimof this topic is to share research addressing neuroprotective strategies for the brain, theirpossible pathways, and the use of pharmacological analogues. Four reviews are about hypoxia. Twochapters address themolecular bases of cognitive impairment in AD. Biochemical and physiologicalaspects of neuroprotective agents focusing on synaptic modifications, neuroprotection followingperinatal asphyxia, and pharmacological- and genetic-targeting strategies for Alzheimer's and Parkinson's diseases are reviewed. Fil: Otero losada, Matilde Estela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina. Universidad Abierta Interamericana. Secretaría de Investigación. Centro de Altos Estudios En Ciencias Humanas y de la Salud - Sede Buenos Aires; Argentina Fil: Wandosell, Francisco G.. Universidad Autónoma de Madrid; España. Consejo Superior de Investigaciones Científicas; España Fil: Capani, Francisco. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina |
description |
Some of the most devastating and costly conditions in the world arise from neurological andneurodegenerative disorders. About one-third of the world's population suffers from neurologicaldiseases, including Parkinson's (PD) and Alzheimer's (AD) diseases, multiple sclerosis, epilepsy, spinal cord injury, and others. Symptoms may show early in childhood or substantially delayedin adolescence or young adulthood. Animal models are powerful tools aiding in understandingneurological pathophysiology towards developing neuroprotective strategies.So far, there are no well-established treatments for brain repair. Hence, neuroprotectionbecomes imperative. Synapses pose major targets for finding new neuroprotective agents.The aimof this topic is to share research addressing neuroprotective strategies for the brain, theirpossible pathways, and the use of pharmacological analogues. Four reviews are about hypoxia. Twochapters address themolecular bases of cognitive impairment in AD. Biochemical and physiologicalaspects of neuroprotective agents focusing on synaptic modifications, neuroprotection followingperinatal asphyxia, and pharmacological- and genetic-targeting strategies for Alzheimer's and Parkinson's diseases are reviewed. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/166054 Otero losada, Matilde Estela; Wandosell, Francisco G.; Capani, Francisco; Neuroprotection in Synaptic Signalling During Neurological Disorders; Frontiers Media; Frontiers in synaptic neuroscience; 13; 746487; 6-2021; 1-3 1663-3563 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/166054 |
identifier_str_mv |
Otero losada, Matilde Estela; Wandosell, Francisco G.; Capani, Francisco; Neuroprotection in Synaptic Signalling During Neurological Disorders; Frontiers Media; Frontiers in synaptic neuroscience; 13; 746487; 6-2021; 1-3 1663-3563 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fnsyn.2021.746487/full info:eu-repo/semantics/altIdentifier/doi/10.3389/fnsyn.2021.746487 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers Media |
publisher.none.fl_str_mv |
Frontiers Media |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613932762791936 |
score |
13.070432 |